Keywords: Share performace, IPOs, Burrill, Financing, Amylin, Genzyme, Myriad Genetics

US Biotech experiences strong first quarter gain, says Burrill

Article | 06 April 2010

Print This

The USA’s biotechnology industry racked up impressive gains for both the month of March and the first quarter of 2010. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in